(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOLYTIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIOLYTIX

ST13

US500000079331690

Class

1, 42, 44

Filing

79331690

Registration

7051161

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

02/04/2024

Trademark type

Word

Nice classes

1, 42, 44

Filing date

11/01/2021

Registration date

05/16/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/16/2023

Last transaction

07/08/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

HARMON, RAYMOND E

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Biolytix AG

Representatives

William A. Scofield, Jr., Esq. Lathrop GPM LLP

Technical classification

Nice Classes

Class 1Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for biochemical analysisother than for medical or veterinary purposes

Class 42

Analytical laboratory serviceschemicalbiochemical and biological diagnostic analyses; performing chemicalbiochemical and biological analyses for scientific purposesnamely analysis of foodanimal feedbeveragestobaccoenvironmental samples; scientific laboratory servicesanalysis and testing of chemical and biological samples; none of the foregoing relating to repairinstallationrentaldesignconsulting regarding for medical and scientific laboratory instruments

Class 44

Medical diagnostic services provided by chemical and biological laboratoriesdiagnostic testing and analysis of medical samples; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes

Publications

History of USPTO decisions and trademark events.

27 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/04/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/12/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/19/2023

FIMP

FINAL DISPOSITION PROCESSED

08/19/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/16/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/16/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/16/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/28/2023

PUBO

PUBLISHED FOR OPPOSITION

02/28/2023

GPNX

NOTIFICATION PROCESSED BY IB

02/27/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/08/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/08/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/08/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/19/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/18/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/18/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/15/2022

RFNT

REFUSAL PROCESSED BY IB

09/06/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/16/2022

RFRR

REFUSAL PROCESSED BY MPU

08/16/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/12/2022

CNRT

NON-FINAL ACTION WRITTEN

08/11/2022

DOCK

ASSIGNED TO EXAMINER

08/10/2022

MAFR

APPLICATION FILING RECEIPT MAILED

02/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/28/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/27/2022

Continuous trademark protection

Get notified about every new filing that threatens BIOLYTIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.